BRIEF-Pfizer And Astellas’ Padcev Plus Keytruda Shows Long-Term Efficacy In First-Line Treatment Of Locally Advanced Or Metastatic Urothelial Cancer
ReutersFeb 10, 2025 10:31 PM
Feb 10 (Reuters) - Astellas Pharma Inc 4503.T:
PFIZER AND ASTELLAS’ PADCEV® (ENFORTUMAB VEDOTIN-EJFV) PLUS KEYTRUDA® (PEMBROLIZUMAB) SHOWS LONG-TERM EFFICACY IN FIRST-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER (LA/MUC)
ASTELLAS PHARMA INC: NO NEW SAFETY SIGNALS IDENTIFIED FROM PHASE 3 EV-302 TRIAL
ASTELLAS PHARMA INC: ENFORTUMAB VEDOTIN PLUS PEMBROLIZUMAB CONTINUES TO DEMONSTRATE SUPERIOR EFFICACY VERSUS CHEMOTHERAPY IN BROAD POPULATION
Source text: ID:nBwbjwWb8a
Further company coverage: 4503.T
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
U.S. Dollar Index: Assessing Its Future Trend Through Macro Analysis of the U.S., Eurozone, Japan, and U.K.
TradingKey - Looking ahead, in the U.S., slowing economic growth combined with ongoing interest rate cuts will exert downward pressure on the dollar. In the Eurozone, weak economic performance and continued ECB rate cuts will likely depreciate the euro, indirectly supporting the U.S. Dollar Index...TradingKey
4 hours ago
Japan July CPI Commentary: Inflation Eases but Remains Elevated, Yen Appreciation Expected
TradingKey - On 22 August 2025, Japan released its inflation data for July. The figures showed that the year-on-year increase in the national Consumer Price Index (CPI) eased to 3.1%, down from 3.3% in June.TradingKey
4 hours ago
Powell's Jackson Hole Speech: For U.S. Stocks, Hawk or Dove Signal Could Be a Lose-Lose?
TradingKey - As U.S. inflation and labor market data show signs of rebalancing, Treasury traders and Wall Street banks have largely priced in a rate cut at the September FOMC meeting — the first of 2025. Yet both a more dovish-than-expected tone and a potential surprise hawkish signal from Fed ChairTradingKey
Mon, Aug 18
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...TradingKey
Mon, Aug 18
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,TradingKey
Wed, Jul 23
